Global law firm Clifford Chance has advised Mitsui & Co., Ltd. (Mitsui) on the creation of Ceva Bussan Animal Health (Ceva Bussan), a joint venture in the Japanese animal health sector that brings together Bussan Animal Health Co., Ltd. (BAH) and Ceva Japan Co., Ltd. As part of the transaction, Mitsui transferred 60% of its shareholding in BAH to Ceva Santé Animale SA (Ceva) and made an additional equity investment in Ceva.
The firm advised on all aspects of the transaction, including structuring the share purchase agreement and shareholders’ arrangement.
Tokyo partner Masafumi Shikakura led the Clifford Chance team, working with partner Natsuko Sugihara, senior associates Hiromu Suemasa and Yuki Hoshinaga in Tokyo, and partner Laurent Schoenstein and counsel Alice Declercq in Paris. Additional support was provided by associates Lewin Lim and Yoshimi Kishimoto in Tokyo and Charlotte Hershkovitch and Leila Medjadji in Paris.
Ceva Bussan combines BAH’s established platform and nationwide sales network in Japan with Ceva’s global animal health expertise and product portfolio. It operates as a full-line animal health company, providing veterinary pharmaceuticals and products for both livestock and companion animals.
